Corundum Trust Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Hold
1,095
3.51% 11
2026
Q1
$1.01M Buy
1,095
+19
+2% +$19.3K 2.3% 14
2025
Q4
$1.16M Sell
1,076
-24
-2% -$22.9K 2.63% 13
2025
Q3
$839K Sell
1,100
-2
-0.2% -$1.49K 1.82% 14
2025
Q2
$859K Sell
1,102
-43
-4% -$33.4K 2.27% 13
2025
Q1
$946K Sell
1,145
-33
-3% -$27.5K 2.73% 11
2024
Q4
$909K Sell
1,178
-27
-2% -$22.4K 2.73% 11
2024
Q3
$1.07M Sell
1,205
-133
-10% -$120K 2.94% 10
2024
Q2
$1.21M Buy
+1,338
New +$1.07M 3.52% 9
2023
Q3
$1.48M Sell
2,747
-5
-0.2% -$2.58K 4.41% 9
2023
Q2
$1.29M Buy
+2,752
New +$1.15M 3.53% 10

Other funds holding LLY

Corundum Trust Company's LLY Position: Q2 2026 in Review

Corundum Trust Company held its Eli Lilly (LLY) position steady in Q2 2026 at 1,095 shares worth $1.31M. The position accounts for 3.51% of the portfolio, ranked #11.

Corundum Trust Company first reported a position in LLY in Q2 2023 and has held it in 11 quarters since. The position peaked at $1.48M in Q3 2023. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Corundum Trust Company held 1,095 shares of Eli Lilly worth $1.31M as of Q2 2026.
  • Corundum Trust Company left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 3.51% of Corundum Trust Company's portfolio in Q2 2026, its #11 holding.
  • Corundum Trust Company first reported a position in Eli Lilly in Q2 2023 and has held it in 11 quarters since.
  • Corundum Trust Company's Eli Lilly position peaked at $1.48M in Q3 2023.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Corundum Trust Company's 13F filing for Q2 2026, filed 29 Jul 2026.